Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvia Nagl

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Comparative and Functional Genomics|July 17, 2008
MicroCore: mapping genome expression to cell pathways and networksManish Patel, Sylvia Nagl
Bioinformatics (Oxford, England)|December 17, 2008
Better bioinformatics through usability analysisDavide Bolchini, Anthony Finkelstein, Vito Perrone, et al.
FEBS Letters|March 12, 2004
Novel sites in the p65 subunit of NF-kappaB interact with TFIIB to facilitate NF-kappaB induced transcriptionChulin Xia, Sandra Watton, Sylvia Nagl, et al.
Seminars in Arthritis and Rheumatism|March 7, 2003
A systematic analysis of sequences of human antiphospholipid and anti-beta2-glycoprotein I antibodies: the importance of somatic mutations and certain sequence motifsIan P Giles, Joanna D Haley, Sylvia Nagl, et al.
Molecular Immunology|December 23, 2003
Somatic mutations to arginine residues affect the binding of human monoclonal antibodies to DNA, histones, SmD and Ro antigenJoanna Haley, Lesley J Mason, Sylvia Nagl, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 12, 2004
Engineering antibodies for clinical applications in cancerKerry Chester, Barbara Pedley, Berend Tolner, et al.
Molecular Immunology|August 12, 2003
Relative importance of different human aPL derived heavy and light chains in the binding of aPL to cardiolipinIan P Giles, Joanna Haley, Sylvia Nagl, et al.
Molecular Immunology|October 18, 2003
Anti-cardiolipin/beta-2 glycoprotein activities co-exist on human anti-DNA antibody light chainsSanjeev Kumar, Sylvia Nagl, J K Kalsi, et al.
Molecular Immunology|October 19, 2004
Beta-2-glycoprotein specificity of human anti-phospholipid antibody resides on the light chain: a novel mechanism for acquisition of cross-reactivity by an autoantibodySanjeev Kumar, Sylvia Nagl, Jatinderpal K Kalsi, et al.
Cancer Research|December 20, 2007
Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomasEthaar El Emir, Uzma Qureshi, Jason L J Dearling, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Comparative and Functional Genomics|July 17, 2008
MicroCore: mapping genome expression to cell pathways and networksManish Patel, Sylvia Nagl
Bioinformatics (Oxford, England)|December 17, 2008
Better bioinformatics through usability analysisDavide Bolchini, Anthony Finkelstein, Vito Perrone, et al.
FEBS Letters|March 12, 2004
Novel sites in the p65 subunit of NF-kappaB interact with TFIIB to facilitate NF-kappaB induced transcriptionChulin Xia, Sandra Watton, Sylvia Nagl, et al.
Seminars in Arthritis and Rheumatism|March 7, 2003
A systematic analysis of sequences of human antiphospholipid and anti-beta2-glycoprotein I antibodies: the importance of somatic mutations and certain sequence motifsIan P Giles, Joanna D Haley, Sylvia Nagl, et al.
Molecular Immunology|December 23, 2003
Somatic mutations to arginine residues affect the binding of human monoclonal antibodies to DNA, histones, SmD and Ro antigenJoanna Haley, Lesley J Mason, Sylvia Nagl, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 12, 2004
Engineering antibodies for clinical applications in cancerKerry Chester, Barbara Pedley, Berend Tolner, et al.
Molecular Immunology|August 12, 2003
Relative importance of different human aPL derived heavy and light chains in the binding of aPL to cardiolipinIan P Giles, Joanna Haley, Sylvia Nagl, et al.
Molecular Immunology|October 18, 2003
Anti-cardiolipin/beta-2 glycoprotein activities co-exist on human anti-DNA antibody light chainsSanjeev Kumar, Sylvia Nagl, J K Kalsi, et al.
Molecular Immunology|October 19, 2004
Beta-2-glycoprotein specificity of human anti-phospholipid antibody resides on the light chain: a novel mechanism for acquisition of cross-reactivity by an autoantibodySanjeev Kumar, Sylvia Nagl, Jatinderpal K Kalsi, et al.
Cancer Research|December 20, 2007
Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomasEthaar El Emir, Uzma Qureshi, Jason L J Dearling, et al.
Pageof 2